SEC Form 4 · accession 0001315406-17-000012
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Norman D Schwartz
Officer — Chairman, President, and CEO · Director · 10% Owner
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 6:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad B Common StockF3 | Jun 1, 2017 | J | 20,588 | $0.00 | A | 236,451 | D | |
| Bio-Rad A Common Stock | holding | — | — | — | 411,252 | D | ||
| Bio-Rad B Common StockF1 | holding | — | — | — | 12,664 | I | By Spouse | |
| Bio-Rad B Common StockF2 | holding | — | — | — | 4,060,054 | I | By Blue Raven Partners, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these shares.
- F2The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F3Distribution from DANSA Partners LTD to the reporting person who is a limited partner.